Jefferies analyst Owen Bennett suggests the heavy investment potentially signals a strategy to penetrate the larger US market. Despite legal limitations on Organigram's exposure to the US, the climate might shift in the next 12-24 months.
The cannabis industry presents a wealth of investment opportunities amidst the current fall in cannabis-company valuations. British American Tobacco Plc's fund infusion could tactically place Organigram to leverage emerging growth possibilities.
OrganiGram股票討論區
$Tilray Brands(TLRY.US)$$ADVISORSHARES PURE US CANNABIS ETF(MSOS.US)$$OrganiGram(OGI.US)$$Akanda(AKAN.US)$ $SNDL Inc(SNDL.US)$$Canopy Growth(CGC.US)$$Cronos Group(CRON.US)$
📊⚡️📊
2/7/2024 🚨🚨🚨
📊⚡️📊
Load small at this dips
Such a good news will be watching this
暫無評論